REDWOOD CITY, Calif., Sept. 23 /PRNewswire/ -- Codexis, Inc., today announced the appointment of Lynn Marcus-Wyner, Ph.D., as Vice President, Intellectual Property. She will be responsible for managing the company's intellectual property strategy, activities, and patent portfolio and will report to Douglas Sheehy, Vice President, General Counsel and Secretary.
Dr. Marcus-Wyner joins Codexis from Danisco A/S, where as Senior Director, Intellectual Assets US, she managed the United States patent department of the Genencor division. Previously, she was in private intellectual property law practice representing clients, including Genencor International, Inc., and Novartis Corporation, and held a legal patent management position at Sandoz Agro Inc. Dr. Marcus-Wyner was also a Patent Attorney at Zeneca Inc. (formerly ICI Americas Inc). Dr. Marcus-Wyner has a J.D. from the University of the Pacific, McGeorge School of Law and a Ph.D. in plant physiology from the University of California, Davis. Prior to law school, Dr. Marcus-Wyner was an Assistant Professor in the Plant and Soil Science Department at the University of Massachusetts, Amherst.
"Building and protecting our intellectual property portfolio is a key success factor for Codexis," Mr. Sheehy said. "Dr. Marcus-Wyner has broad experience counseling life science and bioindustrial companies on intellectual property law matters, and brings a proven track record in managing this important function in our industry," Mr. Sheehy said. "We are very pleased to add her to the Codexis legal team."
Codexis is a leading developer of proprietary biocatalysts that the
company believes have the potential to revolutionize chemistry-based
manufacturing processes across a variety of industries. The company has
used its technology platform to enable biocatalyst-based commercial-scale
drug manufacturing processes and delivered biocatalysts and drug products
to some of the world's leading pharmaceutical companies. Codexis has a
funded research collaboration in the biofuels market, and the company is
pursuing funded collaborations in several other bioindustrial markets,
including carbon management, water treatment and chemicals.
CONTACT: Lyn Christenson, email@example.com,
650-421-8144, or Justin Jackson, firstname.lastname@example.org,
Burns McClellan, 212-213-0006
|SOURCE Codexis, Inc.|
Copyright©2008 PR Newswire.
All rights reserved